Sign in

CIK 0001810182

  • Non-accelerated filer
  • Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850642577
Phone
+1 650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-17 Lettmann Jason CHIEF EXECUTIVE OFFICER Sale −2,230 $1.93 $4K 294,379
2026-08-17 Wong Shelly SVP, FINANCE AND CAO Sale −573 $1.93 $1K 87,828
2026-07-01 Wong Shelly SVP, FINANCE AND CAO Sale −1,404 $2.04 $3K 88,401
2026-04-16 Knight Jeff E. Chief Dev & Operating Officer Grant or award · Stock option (right to buy) +800,000 800,000
2026-04-16 Klencke Barbara Chief Medical Officer Grant or award · Stock option (right to buy) +100,000 100,000
2026-03-19 Lettmann Jason CHIEF EXECUTIVE OFFICER Sale −12,311 $2.17 $27K 293,609
2026-03-19 Pinto Shelly SVP, FINANCE AND CAO Sale −903 $2.17 $2K 86,805
2026-03-03 Klencke Barbara Chief Medical Officer Grant or award · Stock option (right to buy) +700,000 700,000
2026-02-18 Pinto Shelly SVP, FINANCE AND CAO Sale −565 $2.27 $1K 87,708
2026-02-17 Lettmann Jason CHIEF EXECUTIVE OFFICER Shares withheld for taxes −2,201 $2.27 $5K 305,920
2026-02-02 GOODMAN COREY S Director Purchase +3,184,713 $1.57 $5.0M 8,453,038
2026-01-26 Shantharam Harish Chief Financial Officer Grant or award · Stock option (right to buy) +303,000 303,000
2026-01-26 Pinto Shelly SVP, FINANCE AND CAO Grant or award · Stock option (right to buy) +192,000 192,000
2026-01-26 Lettmann Jason CHIEF EXECUTIVE OFFICER Grant or award · Stock option (right to buy) +912,000 912,000
2026-01-20 GOODMAN COREY S Director Grant or award · Stock Option (right to buy) +40,400 40,400
2026-01-20 Garland J. Scott Director Grant or award · Stock option (right to buy) +40,400 40,400
2026-01-20 Sandler Alan B. Director Grant or award · Stock option (right to buy) +10,100 10,100
2026-01-20 Curran Daniel J. Director Grant or award · Stock Option (right to buy) +16,833 16,833
2026-01-20 Takimoto Chris H Director Grant or award · Stock option (right to buy) +40,400 40,400
2026-01-20 Hemrajani Rekha Director Grant or award · Stock option (right to buy) +40,400 40,400

Page 1 of 22 · 432 trades